Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease depressive » increasing depressive (Expand Search), decreased expression (Expand Search)
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
Showing 1 - 20 results of 14,088 for search '(( significant decrease depressive ) OR ( significant ((nn decrease) OR (mean decrease)) ))', query time: 1.19s Refine Results
  1. 1
    Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment

    Mean platelet volume and neutrophil to lymphocyte ratio decrease in patients with depression with antidepressant treatment by AHMET ÖZTÜRK (8077292)

    Published 2022
    “…There was decline both in MPV and NLR which were both statistically significant. Conclusion Decreasing MPV and NLR values with the treatment of depression confirm the involvement of inflammatory processes in the pathophysiology of depression.…”
    Save to List
    Saved in:
  2. 2
    MiR-129-5p levels were decreased in mouse depression models.

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    The combination of CUMS and smoke exposure significantly decreased the expression of pro-apoptosis factors and increase in anti-apoptosis factors when compared to stress or smoke group in the left lung.

    The combination of CUMS and smoke exposure significantly decreased the expression of pro-apoptosis factors and increase in anti-apoptosis factors when compared to stress or smoke g... by Bai-Ping Liu (14164799)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 4
    MS decreases the larger amplitude distribution in adult rats.

    MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

    Published 2023
    Subjects: “…glutamatergic events decreased…”
    Save to List
    Saved in:
  5. 5
    Significant interaction (time by group) for PPTd.

    Significant interaction (time by group) for PPTd. by Einat Kodesh (13132997)

    Published 2022
    “…<p>The measurement of pain pressure threshold (mean±standard error) on the Deltoid (PPTd) showed that responders (black solid line) demonstrated a significant decrease in PPTd following eccentric exercise. …”
    Save to List
    Saved in:
  6. 6
    CUMS or smoke decreased protein concentration of BDNF, but increased TrkB and P75.

    CUMS or smoke decreased protein concentration of BDNF, but increased TrkB and P75. by Bai-Ping Liu (14164799)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 7
    Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and heart rate (HR) across the three conditions.

    Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

    Published 2025
    Save to List
    Saved in:
  8. 8
    <i>Kpna1</i> KO mice show decreased anxiety-like behavior in the elevated plus maze.

    <i>Kpna1</i> KO mice show decreased anxiety-like behavior in the elevated plus maze. by Koki Sakurai (11690201)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 9
    CUMS, smoke or their combination increased pro-inflammatory cytokines production, but decreased peripheral mononuclear cells viability after stimulated by LPS or ConA.

    CUMS, smoke or their combination increased pro-inflammatory cytokines production, but decreased peripheral mononuclear cells viability after stimulated by LPS or ConA. by Bai-Ping Liu (14164799)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 10
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: